Related by context. Frequent words. (Click for all words.) 81 Omeros Corporation 74 NASDAQ SNTA biopharmaceutical 71 Urigen Pharmaceuticals Inc. 71 Targeted Genetics Corporation 69 Nasdaq ATEC 69 VIA Pharmaceuticals 68 Genaera Corporation 68 commercializing therapeutic 68 NASDAQ CRXL 68 Ceragenix Pharmaceuticals Inc. 67 Novelos Therapeutics Inc. 67 ImmunoCellular Therapeutics Ltd. 67 NASDAQ OSIR 67 Inc. NASDAQ QLTI 67 Therapeutic Competitors 67 SANUWAVE Health 66 Inc. NASDAQ MBLX 66 Nasdaq CRXL 66 bio therapeutics 66 Inc Therapeutic Competitors 66 Adherex Technologies Inc. 66 EPIX Pharmaceuticals Inc. 66 * Azixa 66 Crucell NV Euronext 66 Iomai Corporation 66 Transcept Pharmaceuticals 66 AVEO Pharmaceuticals Inc. 66 Chemokine Therapeutics 66 Applied NeuroSolutions 66 Inc. Nasdaq IMGN 65 LYON France BUSINESS WIRE 65 NovaBay Pharmaceuticals Inc. 65 Adeona Pharmaceuticals Inc. 65 novel antibody therapeutics 65 Nasdaq ALTH 65 Barrier Therapeutics Inc. 65 Nastech Pharmaceutical Company 65 Vertex Pharmaceuticals Incorporated 65 MiddleBrook Pharmaceuticals Inc. 65 StromaCel Inc. 65 www.vivus.com 65 Dynavax Technologies Corporation 65 Inc. Nasdaq SUPG 65 OXIS International 65 Immtech Pharmaceuticals Inc. 65 China Aoxing Pharmaceutical 65 NASDAQ LGND 64 Agios Pharmaceuticals 64 NASDAQ OPXA 64 Initiates Phase II 64 Masimo NASDAQ MASI 64 AXYS Design Automation 64 Nasdaq MATK 64 Ambit Biosciences 64 Idera Pharmaceuticals 64 Advancing Drugs 64 commercializing novel 64 Company www.dowjones.com 64 NovaBay Pharmaceuticals 63 Disclaimer c 63 CardioVascular BioTherapeutics Inc. 63 Nasdaq ENMD 63 BioSpecifics Technologies Corp. 63 Advancing Wellness 63 GAITHERSBURG Md. BUSINESS WIRE 63 PRNewswire FirstCall VIASPACE 63 PRNewswire FirstCall Sigma Aldrich 63 Bovie Medical Corporation 63 MorphoSys AG FSE MOR 63 immuno inflammatory diseases 63 Attracting Bullish Investors 63 Fibrocell Science Inc. 63 Regado Biosciences 63 QUALCOMM Incorporated www.qualcomm.com 63 Exploit collaboration 63 BUSINESS WIRE Jan 63 Roche SIX RO 63 HAYWARD Calif. BUSINESS WIRE 63 Senesco Technologies 63 PRNewswire FirstCall Sangamo BioSciences 63 Inc. Nasdaq NEXM 63 Helix BioMedix Inc. 63 MultiCell Technologies 63 Nasdaq VRTX 63 Metabasis Therapeutics Inc. 63 OSI Prosidion 63 Inc. NASDAQ TRGT 63 ImmuneRegen BioSciences Inc. 63 Pluristem Therapeutics Inc. 63 MultiCell Technologies Inc. 63 Company Nasdaq PRGO 63 Archemix Corp. 63 NASDAQ DYAX 63 www.aveopharma.com 63 NASDAQ NWS NWSA 63 IMPAX Laboratories Inc. 63 ARCA biopharma Inc. 62 Connetics Corporation 62 Sangamo BioSciences Inc. 62 ImmunoGen Inc. 62 NASDAQ SCLN